Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer

Figure 4

Postrelapse survival of patients analyzed according to expression of (a) estrogen receptor (ER)-α, (b) phosphorylation of ER-α Ser167, and (c) expression of progesterone receptor (PR), (d) PRA, and (e) PRB. Higher levels of expression or phosphorylation of these factors were associated with a better survival.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us